chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reported back to the pharmacy at 9:25am with his wife indicating he fainted twice. He sat in our lobby and was given water and orange juice. He was evaluated every 10 minutes for symptoms. at 9:51 he was asked to stay for 10 more minutes, but he elected to leave with his wife going to his house.
Following the first vaccine I felt flu like for over a week then I had a 16 day long cycle. I have not had a cycle longer than two days for over 5 years. I continued to feel exhausted and sick but it was tolerable until the second vaccine. After that one I have dizziness, nausea, headaches, no appetite, insomnia, horrible night sweats, stinky sweat, chest pain, hot flashes, can't think straight, high glucose, and swollen glands in my neck.
IZ given at 0900 Tylenol admin. 0930 Mom reports following. "She was fine all day. Around 1600-1630 she started acting sore and getting feverish. Around 1700 she started acting very snuggly, 1730 her eyes became glassy, darting back and forth and no one was home. She looked shocky and started violently having and throwing up. She then started twitching, became extremely shivery and her eyelids closed to half mast, her body became limp like she was going unconscious. I called the hospital and they rec. to bring her to the ER. Half way here she started talking again, around 10-15 min. OK today at 0930.
fever up to 102F from 5/7 8pm to 5/8 2pm (I took 600mg of Tylenol at 1:30pm on 5/8),  expected: soreness or swelling on the arm where I got the shot, headache, body aches experienced tiredness but couldn't sleep for more than  2 hours continuously at night - kept waking up because of the pain/ heat.
Sore arm; Sore to touch; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and PAIN (Sore to touch) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Surgery (multiple shoulder surgeries) since an unknown date. Concomitant products included ATORVASTATIN and LOSARTAN for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and PAIN (Sore to touch). On 14-Mar-2021, PAIN IN EXTREMITY (Sore arm) and PAIN (Sore to touch) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
I began to have a fever with chills and very severe body aches that lasted 3 days after the shot and developed the day after the shot was administered. In addition, I developed a rash on my arm and was bedridden. I took a small walk that day and proceeded to swell up on the left side of my body but it subsided within a few hours. The next day, I suffered a stroke due to blot clotting and the clot flowing to my brain. I had to go to the hospital and was there for a few days.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medication were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of VAQTA lot # L004742, expiration date 22-SEP-2016 (dose and routes of administration were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt passed out approx 1/2 hr p/receiving vax; was taken to hosp, pt released w/no abnormal findings on exam or bloodwork;
About 4 hrs. after receiving flu shot I started a constant cough which lasted about 4 hrs. Then I had chills on & off for about two hrs. No fever & aside from those 2 symptoms felt OK. Next day just muscle aches from coughing along with a very dry mouth and not quite feeling up to par energy wise though I did put it a full days work. The day after that felt  normal.
erythematous rash to lt outer arm/site of inj started 14NOV97 & 2 new papules 19NOV-no fever;seen on 21NOV 2 new areas dissipated-rash, dec erythema rash hadn't significantly changed in 5 days;considered not varicella, per ARNP;titer drawn
developed pain in the arm where the injection was made; This is a spontaneous report received from contactable reporter(s) (Pharmacist).  A 31 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 17Apr2021 10:00 (Batch/Lot number: unknown) at the age of 31 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Single), for Covid-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 17Apr2021, outcome "recovered" (17Apr2021), described as "developed pain in the arm where the injection was made". Therapeutic measures were taken as a result of vaccination site pain.  Additional information: Facility type vaccine was Workplace clinic. lot number was not available/provided to reporter at the time of report completion. Patient received second dose of Pfizer COVID19 vaccine. 2 hours after vaccination developed pain in the arm where the injection was made. The pain was relieved by rolling her arms and performing light exercises with the arm. The pain was completely recovered after 8 hours. The patient was not tested COVID prior vaccination. No Covid tested post vaccination. Patient did not take other vaccine in four weeks and any other medications in two weeks.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported in a literature article and described the occurrence of multiple sclerosis in a adolescent subject who received Hepatitis A. Co-suspect products included sodium chloride for an unknown indication. On an unknown date, 183 days after receiving Hepatitis A vaccine, the subject developed multiple sclerosis. Serious criteria included GSK medically significant. The outcome of multiple sclerosis was unknown. The investigator considered that there was a reasonable possibility that the multiple sclerosis may have been caused by Hepatitis A vaccine. Additional information was provided: This case was reported in a literature article and it described the occurrence of sclerosis multiple in patient of unspecified gender at least 10 years old and less than 26 year old who had received HAVRIX. The patient received the vaccines as part of a clinical trial with the following inclusion criteria: availability for the entire study period and using a highly effective contraceptive method during the study if sexually active. In addition to this, it had the following exclusion criteria: previous meningococcal B or hepatitis A vaccine, any contraindication for hepatitis A vaccination, scheduled to receive at least one dose of human papillomavirus vaccine between visit 1 and 28 days after vaccination 2, previous anaphylactic reaction to any vaccine or vaccine-related component, history of microbiologically proven disease caused by N. meningitidis or N. gonorrhea, current pregnancy or breastfeeding. No further information on the patient's concurrent medical conditions, medical and family history or concomitant medication was provided. On an unspecified date, the patient received 2 doses of HAVRIX following a 0 and 6 months schedule. Dosage: either 720 ELISA units or 1440 ELISA units of viral antigen per 0.5mL or 1.0mL dose (age specific doses according to country specific guidelines). Administration route: intramuscular using a 25gauge, 1inch needle; site was upper deltoid muscle with a 25gauge, 1inch needle. Batch numbers were not provided. In addition to this, the patient was administered 0.5mL normal sterile saline solution for injection (0.9% sodium chloride) as placebo at month 2. On an unspecified date, within 6 months of the second vaccine, the patient was diagnosed with multiple sclerosis. Treatment was unknown. Outcome was unspecified at the time of reporting. The authors commented that this had been considered by the investigator as related to study vaccination. The authors concluded that the "the results presented provide additional data demonstrating that bivalent rLP2086 has an acceptable safety and tolerability profile in healthy individuals greater or equal to 10 to 26 years of age. No new safety concerns were identified in this trial of a vaccine that is important for the prevention of a severe disease".
Headache, Myalgia, fatigue Narrative: missed work following second dose due to above symptoms
pt came into the clinic to get up to date on her vaccines, she has previously received 9 vaccines in another state, and they were added on her chart as a historical administration. hepatitis B adult was given instead of a pediatric dose on Wednesday august 2, 2023.
Red swollen spots - blisters filled with fluid - fever - fussy - loss of appt - lesions in mouth - itchiness all over body - dry lesions - (pt) also tested (+) for pharyngitis. Treatment: ROCEPHIN 250mg, ZOVIRAX 200/5, AUGMENTIN 200/5, BACTROBAN, Triamcinolone.
12MAY92 pt had DTP/OPV/HIB about 3PM; @ 730PM p/feeding pt vomited, choked & became blue; Pt was seen in ER; color nl, strong lusty cry, EOM fine, muscle tone nl; reflex-nl, chest-nl, ear & throat nl;
Headache, fever, body ache, rash, axillary adenopathy, diarrhea.
swelling around my collar bone; This case was reported by a consumer via interactive digital media and described the occurrence of local swelling in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced local swelling. On an unknown date, the outcome of the local swelling was unknown.   It was unknown if the reporter considered the local swelling to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The age group was selected as adult as per the vaccine indication. The patient experienced swelling around his/her collar bone, after receiving the dose of Shingrix. The reporter was asking if that sweeling was a side effect or not. No further information was available.
Patient came to pharmacy on 12/26 and recieved her first dose of the moderna vaccine. Patient called the pharmacy the following day to reoprt she was coughing up blood. Patient was informed to seek emergency care.
SIRVA, specifically bursitis. Have been taking various anti-inflammatories and resting affected shoulder.
Starting a few days before 01/08/2023, I had a horrible migraine with bad nausea and body aches. I threw up the medicine for migraines. I took anti-nausea medicine but threw that up as well. The following morning, I contacted my PCP, who said my symptoms were likely due to having the flu. I got the TAMIFLU on 01/09/2023, and I finished the last of it on 01/14/2023. Honestly, I feel better but not well because I'm still having issues like night time fevers and occasional day time fevers. I did my infusion this past Monday (01/16/2023) and it caused my fever to flare up higher than it was before which means I already had something brewing. I will be seeing the infectious disease doctor for the first time tomorrow. I still feel icky and am having the intermittent fever, but the headache is better. So, I know something is still going on.
parent/guardian indicated patient was older than 5 years and was given the vaccine.  Record review revealed patient was 4 years old at the time of vaccination and would not be eligible at that time.
I experienced shortness of breath that escalated to chest/lung  pain and the sensation that the lungs are compressed by some one's hands. I ended up transported to  Hospital by Fire Department suspecting a heart attack. That was cleared by several tests. While in the Hospital the pain increased and was unbearable. I was given Tramadol and discharged later with heartburn diagnosis.  I have been dealing with heartburn and acid reflux for years and did not experience any such symptoms on the above date and time. later that night the pain increased again and Diclofenac would not help. I used Excedrin and the pain subsided to a bearable level and was able to sleep early in the morning. Throughout this experience, the pain was located specifically in the lungs and I could feel the the bronchia tensed up. I did not feel pain or discomfort anywhere else in my body. The following day, I kept on taking Excedrin a couple of times. Now  the pain decreased but did not go away.
Mother stated that his temp went up to 103.0, he was only 2 mo. of age when that happened.
This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (patient tested positive on 01-AUG-2021 and is experiencing minor symptoms such as a runny nose) and DRUG INEFFECTIVE (Covid-19 positive test after both vaccines) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 025J20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Positive) on 01-Aug-2021. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Aug-2021, the patient experienced COVID-19 (patient tested positive on 01-AUG-2021 and is experiencing minor symptoms such as a runny nose). On an unknown date, the patient experienced DRUG INEFFECTIVE (Covid-19 positive test after both vaccines). At the time of the report, COVID-19 (patient tested positive on 01-AUG-2021 and is experiencing minor symptoms such as a runny nose) and DRUG INEFFECTIVE (Covid-19 positive test after both vaccines) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jul-2021, SARS-CoV-2 antibody test: negative (Negative) Negative. On 01-Aug-2021, SARS-CoV-2 antibody test: positive (Positive) Positive. No concomitant medications were reported. No treatment information was provided.
Exhausted, swelling of whole body from water retention ?,gained approximately 10 pounds, acheie, joints hurt,numbness feeling or pins and needles. Most of swelling  went down 12/ 3/ 21 but still have it in arm.
This patient has been under hospice care for over 2 years at the nursing home. She has had a steady decline with gradual weight loss. She was totally dependent in her care needs. She received the vaccine on 1/2/2021 as part of the facility vaccination campaign. No adverse events noted initially. On 1/3/2021 at 6:06 pm, she was noted on vital sign checks (done every 4 hours for first 72 hours after vaccination) with BP 64/52 but otherwise asymptomatic. Subsequent BP improved. On 1/4/2021 at 4:45 am, pt found with respiratory rate of 30 with otherwise normal vital signs. Tachypnea persisted, so she received liquid morphine 2.5 mg without improvement. Supplemental oxygen was applied. Tachypnea persisted. She had poor oral intake after that point had persistent tachypnea and worsening hypoxemia despite clear lungs on exam. She remained under hospice care and comfort measures were continued. No blood testing or imaging tests were done. She required increasing amounts of oxygen, became hypotensive, and died peacefully on 1/8/2021 at 7:45 pm.
Within one hour of receiving vaccine mother called and stated patient now with red welts and Left cheek/back of neck/ lower back. OK breathing, denies chest tightness referred to ER.
Symptoms started 6/3/21.  Came to the ER and was admitted  to the hospital 6/28/2021 with increasing SOB, dry cough, chills, diarrhea. and nausea.  Required hi level of O2 therapy on admission leading to mechanical ventilation.  On 7/5/21, was transferred to Medical Center for ECMO therapy. Tested positive for Delta variant.  History of COVID-19 in 2020 status post both doses of Johnson and Johnson vaccine.
hard lump in my arm; This case was reported by a consumer via interactive digital media and described the occurrence of induration in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th December 2021, the patient received Shingrix. In December 2021, less than a week after receiving Shingrix, the patient experienced induration. On an unknown date, the outcome of the induration was unknown.   It was unknown if the reporter considered the induration to be related to Shingrix.  Additional details were reported as follows: Age at vaccination was not reported. The patient received a dose of Shingrix and experienced a hard lump in arm. Consent to follow up was not possible as no contact details were available.
States her fingers could not close; she had problems with her wrists and her shoulders; she had problems with her wrists and her shoulders; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77 year-old female patient received bnt162b2 (BNT162B2), administration date 12Feb2022 (Batch/Lot number: unknown) at the age of 76 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious), outcome "unknown", described as "States her fingers could not close"; JOINT INJURY (non-serious), LIMB INJURY (non-serious), outcome "unknown" and all described as "she had problems with her wrists and her shoulders". Relevant laboratory tests and procedures are available in the appropriate section.  The lot number for bnt162b2 was not provided and will be requested during follow up.
C/o nausea BP158/100  Patient hadn't taken his AM medication Lisinopril/HCTZ. Left with BP 130/80 to home
Information has been received from a medical assistant referring to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 05-FEB-2019, the patient was vaccinated with improperly stored PEDVAXHIB (1 injection, via intramuscular, lot # reported as: R0123571, expiration date: 19-MAR-2021; strength and anatomical location were not reported) for prophylaxis. No adverse effect was reported. The PEDVAXHIB was exposed to 0 degree Celsius for 45 minutes. There was no previous temperature excursion. The data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1902USA008818: US-009507513-1903USA006922: US-009507513-1903USA006923: US-009507513-1903USA006924: US-009507513-1903USA006925: US-009507513-1903USA006926: US-009507513-1903USA006927: US-009507513-1903USA006928: US-009507513-1903USA006929: US-009507513-1903USA006930: US-009507513-1903USA006931: US-009507513-1903USA006932: US-009507513-1903USA006933: US-009507513-1903USA006934: US-009507513-1903USA006935: US-009507513-1903USA006937: US-009507513-1903USA006938: US-009507513-1903USA006939: US-009507513-1903USA006940: US-009507513-1903USA006941: US-009507513-1903USA006942: US-009507513-1903USA006943: US-009507513-1903USA006944: US-009507513-1903USA006945: US-009507513-1903USA006946: US-009507513-1903USA006947: US-009507513-1903USA006948: US-009507513-1903USA006949: US-009507513-1903USA006950.
Patient had his covid vaccine had fever and chills for 2-3 days following vaccine and then on the 5th day he began to feel pain in leg and foot making it difficult to walk at times then a few days later noticed the lesions on his leg and foot.
Patient received first vaccine in 3/2021, second in 4/2021 and third "booster" dose in 8/2021. Patient aware he did not meet criteria for a booster dose and received third dose prior to the 6 month recommendation mark. After 2nd dose in 8/2021 he presented to an outside hospital with a platelet count of 1 symptomatic with bruising, nose bleeds and petechiae. Bone marrow biopsy revealed immune thrombocytopenia purpura (ITP). He was admitted for days and received high dose steroids and IVIG. He now follows with a local oncologist office for management.
I woke up I really tired, tired/I got tired and fatigue; headache; when I came to have my breakfast I felt that food doesn't tastes nor regularly as it was before; This is a spontaneous report from a contactable physician (patient). A 75-year-old male patient received bnt162b2 (lot/batch number and expiration date not provided), via an unspecified route of administration, on 18Dec2020 (reported as yesterday of 19Dec2020), at single dose, for COVID. The patient medical history included COVID and changing his taste, both in Apr2020 and not ongoing. The patient's concomitant medications were not reported. It was reported that the patient got COVID himself what it started changing his taste in April and he was sick and come to better at the bottom month and he was fine. He started to work full time. Then he got a vaccine yesterday morning and today (19Dec2020) he woke up he really tired, tired. He know these the side effects of vaccine fatigue, muscle pain and headache but these are not he was concerned. The concern is he is losing his taste that he had when originally diagnosed with COVID in April of 2020. When this morning he got up, he got tired and fatigue and headache then when he came to have his breakfast he felt that food doesn't tastes nor regularly as it was before. The same thing he had before when he diagnosed with COVID in April. His question is, probably this is not connected, question is could that be side effects of vaccine or by the he checked his antibody week ago, he had antibody, could that he got another COVID or it is the side effects of COVID Vaccine? It was also reported that the patient deal with COVID patient every day. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sore arm for 36 hours Tiredness/malaise during most of day after vaccination
headache; Minor arm stiffness; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and MUSCULOSKELETAL STIFFNESS (Minor arm stiffness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 18-Jan-2021, the patient experienced HEADACHE (headache) and MUSCULOSKELETAL STIFFNESS (Minor arm stiffness).   At the time of the report, HEADACHE (headache) and MUSCULOSKELETAL STIFFNESS (Minor arm stiffness) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Minor received dose of Pfizer COVID Vaccine on 10/10/22 and received a second dose on 10/12/2022
Pt developed red, swollen, warm area just below left deltoid muscle. This started the evening of 6/9/04. Pt is instructed to use cold packs on his arm, take Ibuprofen for fever and also Benadryl as needed.  No c/o SOB.
Pt received vaccine around 1:50pm. While sitting in observation post vaccine, pt felt dizzy and lowered his head.  Nurse standing by told pt was having trouble breathing.  Pt couldn't swallow, did not faint.  Nurse gave epi pen 0.3mg at 1:54pm. At 1:58pm, BP was142/87 and pulse 90. EMS arrived at 2pm.  Pt was responsive, a little dizzy but walked to stretcher.